scholarly journals The many faces of islet antigen‐specific CD8 T cells: clues to clinical outcome in type 1 diabetes

Author(s):  
Alice E Wiedeman ◽  
Cate Speake ◽  
Sarah Alice Long
Diabetologia ◽  
2020 ◽  
Vol 63 (6) ◽  
pp. 1174-1185
Author(s):  
Stephanie J. Hanna ◽  
Wendy E. Powell ◽  
Anna E. Long ◽  
Emma J. S. Robinson ◽  
Joanne Davies ◽  
...  

2007 ◽  
Vol 123 ◽  
pp. S10
Author(s):  
Anna Skowera ◽  
Richard Ellis ◽  
Timothy Tree ◽  
Mark Peakman ◽  
Sefina Arif
Keyword(s):  
T Cells ◽  

2017 ◽  
Vol 65 (4) ◽  
pp. 275-284 ◽  
Author(s):  
Rubén Varela-Calvino ◽  
Cristina Calviño-Sampedro ◽  
Iria Gómez-Touriño ◽  
Oscar J. Cordero
Keyword(s):  
T Cells ◽  

2021 ◽  
pp. ji2100362
Author(s):  
Ashley E. Ciecko ◽  
David M. Schauder ◽  
Bardees Foda ◽  
Galina Petrova ◽  
Moujtaba Y. Kasmani ◽  
...  
Keyword(s):  
T Cells ◽  

2021 ◽  
pp. 108893
Author(s):  
Daisuke Chujo ◽  
Akitsu Kawabe ◽  
Maya Matsushita ◽  
Chiharu Tsutsumi ◽  
Fumitaka Haseda ◽  
...  

2019 ◽  
Vol 104 (10) ◽  
pp. 4282-4294 ◽  
Author(s):  
Mikako Takita ◽  
Erika Jimbo ◽  
Tomoyasu Fukui ◽  
Kaoru Aida ◽  
Akira Shimada ◽  
...  

Abstract Context There are scant reports on the pathological changes of the exocrine and endocrine pancreas in fulminant type 1 diabetes mellitus (FT1DM). Objective To clarify the distinct pathological changes in the exocrine as well as the endocrine pancreas shortly after onset of diabetes in FT1DM. Design The exocrine and endocrine pancreases of 3 patients with FT1DM and 17 nondiabetic controls were immunohistochemically examined for islet and exocrine tissue inflammation, infiltrating mononuclear cell (MNC) CD subtype, enterovirus capsid protein 1 (VP1) localization, and CXC chemokine ligand 10 (CXCL10) and CXC chemokine receptor 3 (CXCR3) expressions. Results The median frequency of insulitis in the 3 FT1DM pancreases was 60%. In the nondiabetic control pancreases, no insulitis was observed. In the islets of FT1DM, the numbers of CD45+, CD3+, CD8+, CD68+, and CD11c+ MNCs were significantly higher than those of the control group. In the exocrine pancreas of FT1DM, the numbers of CD3+ T cells, CD8+ T cells, CD68+ macrophages, and CD11c+ dendritic cells were significantly higher than those of the control group. Infiltrating CD8+ T cells, CD68+ macrophages, and CD11c+ dendritic cells were observed around exocrine acinar cells in FT1DM. There was a close association between VP1 and CXCL10 expression in pancreatic exocrine ductal cells and acinar cells as well as islet cells in FT1DM. CXCL10+ exocrine cells were surrounded by CXCR3+ T cells. Conclusion The pathological findings suggested that suppression of the activated CXCL10–CXCR3 axis in the exocrine as well as the endocrine pancreas is a novel therapeutic target in FT1DM and possibly in enterovirus-associated acute-onset type 1 diabetes.


2020 ◽  
Vol 5 (44) ◽  
pp. eaax8767 ◽  
Author(s):  
Xiaomin Wen ◽  
Junbao Yang ◽  
Eddie James ◽  
I-Ting Chow ◽  
Helena Reijonen ◽  
...  

The DRB1*15:01-DQB1*06:02 (DR1501-DQ6) haplotype is linked to dominant protection from type 1 diabetes, but the cellular mechanism for this association is unclear. To address this question, we identified multiple DR1501- and DQ6-restricted glutamate decarboxylase 65 (GAD65) and islet-specific glucose-6-phosphatase catalytic subunit–related protein (IGRP)–specific T cell epitopes. Three of the DR1501/DQ6-restricted epitopes identified were previously reported to be restricted by DRB1*04:01/DRB1*03:01/DQB1*03:02. We also used specific class II tetramer reagents to assess T cell frequencies. Our results indicated that GAD65- and IGRP-specific effector and CD25+CD127−FOXP3+ regulatory CD4+ T cells were present at higher frequencies in individuals with the protective haplotype than those with susceptible or neutral haplotypes. We further confirmed higher frequencies of islet antigen–specific effector and regulatory CD4+ T cells in DR1501-DQ6 individuals through a CD154/CD137 up-regulation assay. DR1501-restricted effector T cells were capable of producing interferon-γ (IFN-γ) and interleukin-4 (IL-4) but were more likely to produce IL-10 compared with effectors from individuals with susceptible haplotypes. To evaluate their capacity for antigen-specific regulatory activity, we cloned GAD65 and IGRP epitope–specific regulatory T cells. We showed that these regulatory T cells suppressed DR1501-restricted GAD65- and IGRP-specific effectors and DQB1*03:02-restricted GAD65-specific effectors in an antigen-specific fashion. In total, these results suggest that the protective DR1501-DQ6 haplotype confers protection through increased frequencies of islet-specific IL-10–producing T effectors and CD25+CD127−FOXP3+ regulatory T cells.


Sign in / Sign up

Export Citation Format

Share Document